1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients

Purpose: The present study reports the preliminary outcomes in terms of adverse events and quality of life in the first 100 patients treated with 1.5T MR-guided daily-adaptive stereotactic body radiotherapy for prostate cancer. Methods: From October 2019 to December 2020, 100 patients, enrolled in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alongi, Filippo, Rigo, Michele, Figlia, Vanessa, Nicosia, Luca, Mazzola, Rosario, Giaj Levra, Niccolò, Ricchetti, Francesco, Trapani, Giovanna, Attinà, Giorgio, Vitale, Claudio, Pastorello, Edoardo, De Simone, Antonio, Gurrera, Davide, Naccarato, Stefania, Sicignano, Gianluisa, Ruggieri, Ruggero, Cuccia, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785799/
https://www.ncbi.nlm.nih.gov/pubmed/36556203
http://dx.doi.org/10.3390/jpm12121982

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785799/
https://www.ncbi.nlm.nih.gov/pubmed/36556203
http://dx.doi.org/10.3390/jpm12121982

Ejemplares similares